Sodium Chloride Injection 0.9%, USP - Recall of Three Lots due to the Potential for Leakage of the Parenteral/intravenous Solution Bag

Imipenem and Cilastatin for Injection 500 mg/500 mg Single-Dose Vials - Incorrect Labelling Information

FASLODEX (fulvestrant) - Risk of Unnecessary Therapy Modification due to Falsely Elevated Estradiol Levels

PRIMAXIN 500 (imipenem and cilastatin sodium) for injection - Incorrect Labelling Information

ESSURE (permanent birth control system) - Risk of Serious Complications

ADEMPAS (riociguat) - New Contraindication for Patients with Pulmonary Hypertension Associated with Idiopathic Interstitial Pneumonias (PH-IIP)

FLUOROQUINOLONES - Risk of Disabling and Persistent Serious Adverse Reactions

BLINCYTO (blinatumomab) - Risk of Pancreatitis

REVOLADE (eltrombopag) - Risk of Severe Hepatotoxicity

Hospital Beds - Risk of Patient Entrapment

LivaNova Stöckert 3T Heater-Cooler Device - Risk of Mycobacterium chimaera Infections

Zarontin (ethosuximide) - Defective Capsules Associated with Reduced Efficacy (Increased Frequency of Seizures)

EpiPen (epinephrine USP) Auto-Injector - Interim Order allowing the importation of AUVI-Q in response to shortages of EpiPen and EpiPen Jr

Iodinated Contrast Media - Potential Risk of Hypothyroidism

Solu-Cortef (hydrocortisone sodium succinate for injection) 100 mg/2 mL single-dose Act-O-Vial - Recalled Lots due to Potential for Dosing Error